nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA4—autonomic nervous system—conduct disorder	0.0565	0.289	CbGeAlD
Galantamine—CHRNA5—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0372	0.0463	CbGpPWpGaD
Galantamine—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0282	0.0351	CbGpPWpGaD
Galantamine—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0248	0.0309	CbGpPWpGaD
Galantamine—CHRNA5—brain—conduct disorder	0.0201	0.103	CbGeAlD
Galantamine—CHRNB3—brain—conduct disorder	0.0182	0.0934	CbGeAlD
Galantamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0179	0.0222	CbGpPWpGaD
Galantamine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0172	0.0214	CbGpPWpGaD
Galantamine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0171	0.0213	CbGpPWpGaD
Galantamine—CHRNA9—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0165	0.0205	CbGpPWpGaD
Galantamine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0154	0.0191	CbGpPWpGaD
Galantamine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0153	0.019	CbGpPWpGaD
Galantamine—CHRNA6—brain—conduct disorder	0.0152	0.078	CbGeAlD
Galantamine—CHRNB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0144	0.0179	CbGpPWpGaD
Galantamine—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0138	0.0172	CbGpPWpGaD
Galantamine—CHRNB4—brain—conduct disorder	0.0138	0.0708	CbGeAlD
Galantamine—CHRNA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0137	0.017	CbGpPWpGaD
Galantamine—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.013	0.0162	CbGpPWpGaD
Galantamine—CHRNA9—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0124	0.0154	CbGpPWpGaD
Galantamine—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0123	0.0152	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0108	0.0135	CbGpPWpGaD
Galantamine—ACHE—Biogenic Amine Synthesis—COMT—conduct disorder	0.0104	0.0129	CbGpPWpGaD
Galantamine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0104	0.0129	CbGpPWpGaD
Galantamine—ACHE—Biogenic Amine Synthesis—MAOA—conduct disorder	0.0103	0.0129	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0103	0.0128	CbGpPWpGaD
Galantamine—CHRNG—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0098	0.0122	CbGpPWpGaD
Galantamine—CHRNA1—brain—conduct disorder	0.00951	0.0487	CbGeAlD
Galantamine—CHRNA9—Neuronal System—GABRA2—conduct disorder	0.0095	0.0118	CbGpPWpGaD
Galantamine—CHRNE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00922	0.0115	CbGpPWpGaD
Galantamine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00912	0.0113	CbGpPWpGaD
Galantamine—CHRNB2—brain—conduct disorder	0.00875	0.0448	CbGeAlD
Galantamine—CHRNA3—brain—conduct disorder	0.00848	0.0434	CbGeAlD
Galantamine—CHRNB3—Neuronal System—GABRA2—conduct disorder	0.00831	0.0103	CbGpPWpGaD
Galantamine—CHRNA2—brain—conduct disorder	0.00789	0.0404	CbGeAlD
Galantamine—CHRNA5—Neuronal System—GABRA2—conduct disorder	0.00787	0.00978	CbGpPWpGaD
Galantamine—CHRNA6—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00779	0.00968	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—GABRA2—conduct disorder	0.00751	0.00933	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—SLC6A4—conduct disorder	0.0075	0.00932	CbGpPWpGaD
Galantamine—CHRNB1—brain—conduct disorder	0.00734	0.0376	CbGeAlD
Galantamine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00725	0.00901	CbGpPWpGaD
Galantamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00718	0.00892	CbGpPWpGaD
Galantamine—CHRNE—Neuronal System—GABRA2—conduct disorder	0.00706	0.00878	CbGpPWpGaD
Galantamine—CHRFAM7A—brain—conduct disorder	0.00686	0.0351	CbGeAlD
Galantamine—CHRNB2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00686	0.00852	CbGpPWpGaD
Galantamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00657	0.00816	CbGpPWpGaD
Galantamine—ACHE—brain—conduct disorder	0.00636	0.0326	CbGeAlD
Galantamine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00623	0.00774	CbGpPWpGaD
Galantamine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00617	0.00766	CbGpPWpGaD
Galantamine—ACHE—Melatonin metabolism and effects—MAOA—conduct disorder	0.0061	0.00758	CbGpPWpGaD
Galantamine—CHRNA9—Transmission across Chemical Synapses—COMT—conduct disorder	0.00597	0.00742	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—GABRA2—conduct disorder	0.00597	0.00742	CbGpPWpGaD
Galantamine—CHRNA9—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00593	0.00737	CbGpPWpGaD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00586	0.00728	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—CGA—conduct disorder	0.00576	0.00716	CbGpPWpGaD
Galantamine—CHRNA7—brain—conduct disorder	0.00554	0.0284	CbGeAlD
Galantamine—CHRNA4—brain—conduct disorder	0.00547	0.028	CbGeAlD
Galantamine—CHRND—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00545	0.00678	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0054	0.00671	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00531	0.0066	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—GABRA2—conduct disorder	0.00525	0.00653	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00522	0.00648	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00518	0.00644	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—CGA—conduct disorder	0.00514	0.00639	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00508	0.00631	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—COMT—conduct disorder	0.00495	0.00615	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00494	0.00614	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00491	0.0061	CbGpPWpGaD
Galantamine—CHRNG—Transmission across Chemical Synapses—COMT—conduct disorder	0.00472	0.00586	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00469	0.00582	CbGpPWpGaD
Galantamine—CHRNG—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00469	0.00582	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00464	0.00576	CbGpPWpGaD
Galantamine—CHRNA9—Neuronal System—COMT—conduct disorder	0.00457	0.00568	CbGpPWpGaD
Galantamine—CHRNA9—Neuronal System—MAOA—conduct disorder	0.00454	0.00564	CbGpPWpGaD
Galantamine—CHRNE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00444	0.00551	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0044	0.00547	CbGpPWpGaD
Galantamine—CHRNE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0044	0.00547	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00434	0.00539	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00418	0.0052	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—GABRA2—conduct disorder	0.00418	0.00519	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—GABRA2—conduct disorder	0.00414	0.00514	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—DRD4—conduct disorder	0.00408	0.00507	CbGpPWpGaD
Galantamine—CHRNB3—Neuronal System—COMT—conduct disorder	0.004	0.00497	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.004	0.00497	CbGpPWpGaD
Galantamine—CHRNB3—Neuronal System—MAOA—conduct disorder	0.00397	0.00493	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00382	0.00475	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—COMT—conduct disorder	0.00379	0.00471	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—GABRA2—conduct disorder	0.00378	0.0047	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—MAOA—conduct disorder	0.00376	0.00468	CbGpPWpGaD
Galantamine—CHRNA6—Transmission across Chemical Synapses—COMT—conduct disorder	0.00375	0.00466	CbGpPWpGaD
Galantamine—CHRNA6—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00372	0.00463	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00363	0.00451	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—COMT—conduct disorder	0.00362	0.00449	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—GABRA2—conduct disorder	0.00359	0.00446	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—MAOA—conduct disorder	0.00359	0.00446	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—GABRA2—conduct disorder	0.00355	0.00441	CbGpPWpGaD
Galantamine—CHRNE—Neuronal System—COMT—conduct disorder	0.0034	0.00422	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—GABRA2—conduct disorder	0.00338	0.00419	CbGpPWpGaD
Galantamine—CHRNE—Neuronal System—MAOA—conduct disorder	0.00338	0.00419	CbGpPWpGaD
Galantamine—CHRNB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.0033	0.0041	CbGpPWpGaD
Galantamine—CHRNB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00328	0.00407	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00326	0.00405	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00315	0.00391	CbGpPWpGaD
Galantamine—BCHE—brain—conduct disorder	0.00313	0.016	CbGeAlD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00296	0.00368	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—GABRA2—conduct disorder	0.00293	0.00364	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—COMT—conduct disorder	0.00287	0.00357	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—MAOA—conduct disorder	0.00285	0.00354	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00273	0.00339	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00272	0.00339	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—COMT—conduct disorder	0.00262	0.00326	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00261	0.00324	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—COMT—conduct disorder	0.0026	0.00323	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00258	0.00321	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00257	0.00319	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—COMT—conduct disorder	0.00253	0.00314	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—MAOA—conduct disorder	0.00251	0.00312	CbGpPWpGaD
Galantamine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0025	0.00311	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00243	0.00302	CbGpPWpGaD
Galantamine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00241	0.003	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00238	0.00295	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00236	0.00293	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—COMT—conduct disorder	0.00225	0.0028	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00224	0.00278	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00223	0.00277	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00223	0.00277	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00223	0.00277	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00222	0.00275	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00212	0.00263	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00211	0.00262	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—GABRA2—conduct disorder	0.00209	0.00259	CbGpPWpGaD
Galantamine—CYP2D6—brain—conduct disorder	0.00207	0.0106	CbGeAlD
Galantamine—CHRND—Neuronal System—COMT—conduct disorder	0.00201	0.0025	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—MAOA—conduct disorder	0.002	0.00248	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—COMT—conduct disorder	0.00199	0.00247	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—MAOA—conduct disorder	0.00198	0.00246	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—GABRA2—conduct disorder	0.00186	0.00231	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.00184	0.00228	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00183	0.00227	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—COMT—conduct disorder	0.00182	0.00226	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00182	0.00226	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—MAOA—conduct disorder	0.00181	0.00225	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—COMT—conduct disorder	0.00173	0.00215	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00173	0.00215	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—MAOA—conduct disorder	0.00172	0.00213	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—COMT—conduct disorder	0.00171	0.00212	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—MAOA—conduct disorder	0.0017	0.00211	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—COMT—conduct disorder	0.00162	0.00202	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—MAOA—conduct disorder	0.00161	0.002	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—EP300—conduct disorder	0.00149	0.00186	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—EP300—conduct disorder	0.00141	0.00175	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—COMT—conduct disorder	0.00141	0.00175	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—MAOA—conduct disorder	0.0014	0.00174	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00136	0.00169	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00131	0.00163	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0013	0.00162	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00126	0.00156	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00118	0.00147	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00117	0.00145	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00116	0.00144	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00113	0.00141	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00112	0.0014	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CGA—conduct disorder	0.00109	0.00135	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—COMT—conduct disorder	0.001	0.00125	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MAOA—conduct disorder	0.000998	0.00124	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CGA—conduct disorder	0.00097	0.00121	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000962	0.0012	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—COMT—conduct disorder	0.000896	0.00111	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MAOA—conduct disorder	0.00089	0.00111	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000742	0.000922	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000607	0.000754	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000603	0.000749	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000599	0.000744	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000583	0.000725	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CGA—conduct disorder	0.000561	0.000697	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CGA—conduct disorder	0.0005	0.000621	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000397	0.000493	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000394	0.00049	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000391	0.000486	CbGpPWpGaD
Galantamine—ACHE—Metabolism—COMT—conduct disorder	0.000253	0.000314	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MAOA—conduct disorder	0.000251	0.000312	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000244	0.000303	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CGA—conduct disorder	0.00023	0.000286	CbGpPWpGaD
Galantamine—BCHE—Metabolism—COMT—conduct disorder	0.000226	0.000281	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MAOA—conduct disorder	0.000224	0.000279	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000217	0.00027	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CGA—conduct disorder	0.00015	0.000187	CbGpPWpGaD
Galantamine—ACHE—Metabolism—EP300—conduct disorder	0.000109	0.000135	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—COMT—conduct disorder	0.000104	0.000129	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MAOA—conduct disorder	0.000103	0.000128	CbGpPWpGaD
Galantamine—BCHE—Metabolism—EP300—conduct disorder	9.68e-05	0.00012	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—COMT—conduct disorder	6.79e-05	8.43e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MAOA—conduct disorder	6.74e-05	8.37e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—EP300—conduct disorder	4.45e-05	5.53e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—EP300—conduct disorder	2.91e-05	3.62e-05	CbGpPWpGaD
